Follow
Meri Rogava
Meri Rogava
Columbia University Medical Center
Verified email at cumc.columbia.edu - Homepage
Title
Cited by
Cited by
Year
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
T Bald, T Quast, J Landsberg, M Rogava, N Glodde, D Lopez-Ramos, ...
Nature 507 (7490), 109-113, 2014
6472014
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
J Landsberg, J Kohlmeyer, M Renn, T Bald, M Rogava, M Cron, M Fatho, ...
Nature 490 (7420), 412-416, 2012
6072012
A molecular single-cell lung atlas of lethal COVID-19
JC Melms, J Biermann, H Huang, Y Wang, A Nair, S Tagore, I Katsyv, ...
Nature 595 (7865), 114-119, 2021
4602021
A single-cell landscape of high-grade serous ovarian cancer
B Izar, I Tirosh, EH Stover, I Wakiro, MS Cuoco, I Alter, C Rodman, ...
Nature medicine 26 (8), 1271-1279, 2020
2972020
Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy
N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ...
Immunity 47 (4), 789-802. e9, 2017
2352017
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
CJ Frangieh, JC Melms, PI Thakore, KR Geiger-Schuller, P Ho, ...
Nature genetics 53 (3), 332-341, 2021
1352021
A stochastic model for immunotherapy of cancer
M Baar, L Coquille, H Mayer, M Hölzel, M Rogava, T Tüting, A Bovier
Scientific reports 6 (1), 24169, 2016
682016
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
J Biermann, JC Melms, AD Amin, Y Wang, LA Caprio, A Karz, S Tagore, ...
Cell 185 (14), 2591-2608. e30, 2022
592022
A preclinical model of malignant peripheral nerve sheath tumor-like melanoma is characterized by infiltrating mast cells
M Hoelzel, J Landsberg, N Glodde, T Bald, M Rogava, S Riesenberg, ...
Cancer research 76 (2), 251-263, 2016
352016
Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity
JC Melms, S Vallabhaneni, CE Mills, C Yapp, JY Chen, E Morelli, ...
Cancer research 80 (4), 798-810, 2020
252020
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators
A Obradovic, C Ager, M Turunen, T Nirschl, M Khosravi-Maharlooei, ...
Cancer cell 41 (5), 933-949. e11, 2023
142023
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
P Ho, JC Melms, M Rogava, CJ Frangieh, J Poźniak, SB Shah, Z Walsh, ...
Cancer Cell 41 (7), 1207-1221. e12, 2023
132023
Tumor cell intrinsic Toll‐like receptor 4 signaling promotes melanoma progression and metastatic dissemination
M Rogava, AD Braun, TC van der Sluis, N Shridhar, T Tüting, E Gaffal
International Journal of Cancer 150 (1), 142-151, 2022
82022
The CD58: CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity
P Ho, JC Melms, M Rogava, CJ Frangieh, SB Shah, Z Walsh, O Kyrysyuk, ...
BioRxiv, 2022.03. 21.485049, 2022
62022
The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy
J Ruotsalainen, D Lopez‐Ramos, M Rogava, N Shridhar, N Glodde, ...
Clinical & Translational Immunology 10 (4), e1276, 2021
62021
CXCR3: Here to stay to enhance cancer immunotherapy?
M Rogava, B Izar
EBioMedicine 49, 11-12, 2019
42019
A stochastic individual-based model for immunotherapy of cancer
M Baar, L Coquille, H Mayer, M Hölzel, M Rogava, T Tüting, A Bovier
arXiv preprint arXiv:1505.00452, 2015
32015
Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation
M Rogava, TJ Aprati, WY Chi, JC Melms, C Hug, SH Davis, EM Earlie, ...
Nature Cancer, 1-15, 2024
12024
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
NK Altorki, ZH Walsh, JC Melms, JL Port, BE Lee, A Nasar, C Spinelli, ...
Nature Communications 14 (1), 8435, 2023
12023
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response
CR Ager, M Zhang, M Chaimowitz, S Bansal, S Tagore, A Obradovic, ...
Journal for Immunotherapy of Cancer 11 (9), 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20